INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,497,123 | -36.8% | 59,292 | -47.2% | 0.04% | -49.3% |
| Q2 2023 | $2,369,361 | -34.2% | 112,292 | -46.9% | 0.08% | -32.4% |
| Q1 2023 | $3,603,347 | -99.9% | 211,340 | +80.9% | 0.11% | +131.2% |
| Q3 2022 | $2,517,000,000 | -14.2% | 116,844 | -21.5% | 0.05% | +11.6% |
| Q2 2022 | $2,935,000,000 | +186.6% | 148,844 | +272.1% | 0.04% | +115.0% |
| Q2 2019 | $1,024,000,000 | -60.4% | 40,000 | -51.7% | 0.02% | -47.4% |
| Q3 2017 | $2,586,000,000 | -38.1% | 82,858 | -58.7% | 0.04% | -57.3% |
| Q1 2015 | $4,177,000,000 | +800.2% | 200,837 | +569.5% | 0.09% | +1012.5% |
| Q4 2014 | $464,000,000 | -54.2% | 30,000 | -61.3% | 0.01% | -52.9% |
| Q3 2014 | $1,012,000,000 | – | 77,573 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |